Compare PRTA & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | NATR |
|---|---|---|
| Founded | 2012 | 1972 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 431.6M |
| IPO Year | N/A | N/A |
| Metric | PRTA | NATR |
|---|---|---|
| Price | $9.05 | $24.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $18.86 | ★ $21.33 |
| AVG Volume (30 Days) | ★ 511.6K | 95.5K |
| Earning Date | 02-19-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $11,786,000.00 | ★ $474,542,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | $1,183.79 | $3.44 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | N/A | ★ 6.62 |
| 52 Week Low | $4.32 | $11.01 |
| 52 Week High | $16.67 | $24.97 |
| Indicator | PRTA | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 69.16 |
| Support Level | $8.65 | $23.50 |
| Resistance Level | $10.53 | $24.97 |
| Average True Range (ATR) | 0.48 | 0.85 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 21.81 | 97.45 |
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.